Evidence map›Paper›PMID 41276719›Full record

ArticleEndocrine pathology2025

Follicular Thyroid Carcinoma Relapse Cases - Revisited by X-ray 3D Virtual Histology.

Kiarash Tajbakhsh, Olga Stanowska, Jonas Bossart, Marija Buljan, Antonia Neels, Martina T Mogl, Catarina Alisa Kunze, Guenther Klein, Wolfgang Hulla, Rene Brillmann and 5 more

Abstract read
In one paragraph

Article in Endocrine pathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kiarash Tajbakhsh *Center for X-ray Analytics, Swiss Federal Laboratories for Materials Science and Technology (Empa), Dubendorf, 8600, Switzerland.
Olga Stanowska *Institute of Tissue Medicine and Pathology, University of Bern, Bern, 3008, Switzerland.
Jonas BossartNanomaterials in Health, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
Marija BuljanNanomaterials in Health, Swiss Federal Laboratories for Materials Science and Technology (Empa), St. Gallen, 9014, Switzerland.
Antonia NeelsCenter for X-ray Analytics, Swiss Federal Laboratories for Materials Science and Technology (Empa), Dubendorf, 8600, Switzerland.
Martina T MoglCharité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Catarina Alisa KunzeInstitute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117, Berlin, Germany.
Guenther KleinLandesklinikum Wiener Neustadt, Vienna, Austria.
Wolfgang HullaLandesklinikum Wiener Neustadt, Vienna, Austria.
Rene BrillmannJakob-Erdheim Institute of Pathology and Clinical Bacteriology, Wiener Gesundheitsverbund Klinik Hietzing, Vienna, Austria.
Sabine KirchnawyKlinik Landstrasse, Department of Surgery, Wiener Gesundheitsverbund, Vienna, Austria.
Michael HermannKlinik Landstrasse, Department of Surgery, Wiener Gesundheitsverbund, Vienna, Austria.
Reto KaderliDepartment of Visceral Surgery and Medicine, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.
Robert ZborayCenter for X-ray Analytics, Swiss Federal Laboratories for Materials Science and Technology (Empa), Dubendorf, 8600, Switzerland. robert.zboray@empa.ch.
Aurel PerrenInstitute of Tissue Medicine and Pathology, University of Bern, Bern, 3008, Switzerland. aurel.perren@unibe.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis and prognosis of follicular thyroid neoplasms are based on the identification of capsular and vascular invasion. Although conventional histology allows accurate classification in most cases, its inherent limitations in tissue sampling can result in misjudgment of both the presence and extent of invasion, and occasionally result in diagnostic inaccuracies. Consequently, unexpected tumor recurrence or overtreatment still represent significant clinical challenges. To mitigate these limitations, emerging diagnostic approaches are exploring advanced imaging modalities. X-ray 3D virtual histology has been reported to enable non-destructive and comprehensive sampling of the entire tumor volume embedded in formalin-fixed paraffin-embedded blocks. In thisstudy, the X-ray 3D virtual histology technique is first evaluated by classifying 99 follicular thyroid carcinomas and 31 follicular adenomas, achieving an accuracy of 89.2%. It is then applied to tissue blocks from five relapse cases that were postoperatively diagnosed as adenomas using conventional histology. Three of five tumors exhibited at least one unequivocal focus of vascular invasion, reinforcing that even a single well-defined focus portends significant risk of recurrence and distant metastasis. Although histological confirmation at this stage remained necessary, X-ray 3D virtual histology proved to be a valuable screening method.

Indexed as

Adenocarcinoma, FollicularImaging, Three-DimensionalNeoplasm Recurrence, LocalThyroid NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedDigital pathologyFollicular thyroid neoplasmsMicro-CTX-ray 3D virtual histology

Identifiers

PMID41276719
PMCPMC12641037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.